Mechanistically, FDFT1 knockdown decreases cholesterol and bile acid levels in HCC cells and promotes hepatocyte nuclear factor 4 alpha (HNF4A) transcriptional activity. Here, FDFT1 is linked to hepatocellular carcinoma.